Ultomiris Solution, Concentrate
Substitutes & Crosswalk NDC 25682-022

The similar products listed below help you identify alternative medications based on regulatory status, active ingredients, and administration routes. Identify therapeutic equivalents and alternative medications for Ultomiris (NDC 25682-022). This cross-referenced list provides clinically relevant matches based on the following criteria:

• Generic Bioequivalence: Products sharing the generic name: Ravulizumab.
• Administration Consistency: Same Route (intravenous) and Dosage Form (solution, concentrate).
• Brand Alternatives: Different proprietary names for the same chemical entity.

This clinical crossover tool is designed for healthcare professionals, pharmacists, and patients to safely compare substitute products and manage medication availability.